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Disruption of the Jak1 Gene Demonstrates
Obligatory and Nonredundant Roles of the Jaks
in Cytokine-Induced Biologic Responses
A role for Jaks in cytokine signaling was initially identi-
fied using mutagenized human fibrosarcoma cell lines
that lacked individual Jak proteins and displayed unique
patterns of biologic unresponsiveness to IFNa or IFNg
(Velazquez et al., 1992; MuÈ ller et al., 1993; Watling et
Scott J. Rodig,* Marco A. Meraz,*
J. Michael White,* Pat A. Lampe,²
Joan K. Riley,* Cora D. Arthur,*
Kathleen L. King,³ Kathleen C. F. Sheehan,*
Li Yin,* Diane Pennica,³ Eugene M. Johnson, Jr.,²
al., 1993). This work demonstrated that distinct combi-and Robert D. Schreiber*§
nations of Jaks wererequired for the induction of cellular*Center for Immunology and Department of Pathology
responses to type I versus type II interferons. However,²Department of Molecular Biology and Pharmacology
subsequent studies that sought to define a role for JaksWashington University School of Medicine
in signaling by other cytokine receptors monitored onlySt. Louis, Missouri 63110
whether particular Jaks became phosphorylated and/³Departments of Molecular Oncology and
or activated following in vitro treatment of a cell withProtein Chemistry
different cytokines. This approach often produced con-Genentech, Inc.
flicting results and failed to define a causal relationshipSouth San Francisco, California 94080
between cytokine-dependent Jak activation and the in-
duction of a biologic response (Ihle et al., 1995). This
problem has been most evident for the family of recep-Summary
tors that utilizes the gp130 receptor subunit (i.e., the
receptors for IL-6, IL-11, leukemia inhibitory factor [LIF],Herein we report the generation of mice lacking the
oncostatin M [OSM], ciliary neurotrophic factor [CNTF],ubiquitously expressed Janus kinase, Jak1. Jak12/2
and cardiotrophin-1 [CT-1] [Kishimoto et al., 1995]). Bymice are runted at birth, fail to nurse, and die perina-
monitoring the ability of ligands of the gp130 receptortally. Although Jak12/2 cells are responsive to many
family to induce Jak and STAT activation in cells engi-cytokines, they fail to manifest biologic responses to
neered to overexpress particular Jaks, one group con-cytokines that bind to three distinct families of cyto-
cluded that Jaks can associate in a nonselective mannerkine receptors. These include all class II cytokine re-
with certain cytokine receptor subunits (Stahl et al.,ceptors, cytokine receptors that utilize the gc subunit
1994). In contrast, using a Jak1-deficient tumor cell line,for signaling, and the family of cytokine receptors that
another group reported that Jak1 was indeed requireddepend on the gp130 subunit for signaling. Our results
for IL-6±dependent induction of the IRF-1 transcriptionthus demonstrate that Jak1 plays an essential and
factor in vitro (Guschin et al., 1995). However, no sub-nonredundant role in promoting biologic responses
sequent experiments were performed to determineinduced by a select subset of cytokine receptors, in-
whether Jak1-deficient cells were capable of develop-cluding those in which Jak utilization was thought to
ing a full biologic response. Thus, it remains unclearbe nonspecific.
whether, under physiologic conditions, Jaks participate
in a specific manner in effecting Jak-STAT pathway±Introduction
dependent biologic responses.
One problem impeding the elucidation of the physio-
Cytokines that bind to class I or class II cytokine recep-
logic roles of these enzymes is the absence of mamma-
tors employ the Jak-STAT signaling pathway to manifest
lian models of Jak protein deficiency. To date, the only
many of their biologic effects on cells (Darnell et al.,
known Jak abnormality is that found in Jak3 gene±
1994; Ihle et al., 1995; Darnell, 1997; O'Shea, 1997). This targeted mice and Jak3-deficient human SCID patients
pathway consists of four Janus family protein tyrosine
(Nosaka et al., 1995; Park et al., 1995; Russell et al., 1995;
kinases (Jaks) and a family of seven latent cytosolic
Thomis et al.,1995). The analysis of these individuals has
transcription factors known as signal transducers and
revealed that Jak3 associates exclusively with a single
activators of transcription (STATs). cytokine receptor subunit (gc) and functions predomi-Recent work using mutagenized cell lines and gene- nantly to promote lymphopoiesis. Thus, due to its highly
targeted mice has shown that the STATs play a major restricted nature, Jak3 deficiency does not provide a
role in determining cytokine signaling specificity (Bach suitable system to evaluate the generalized physiologic
et al., 1997; Darnell, 1997; O'Shea, 1997). Distinct STAT functions of the Jaks.
proteins are recruited to individual ligated cytokine re- In contrast, the other members of the Janus kinase
ceptors, where they undergo activation and dimeriza- family (Jak1, Jak2, and Tyk2) are ubiquitously expressed
tion. Activated STAT dimers then translocate to the nu- and interact with many different cytokine receptor sub-
cleus, where they bind to the promoter regions of units (Darnell et al., 1994; Ihle et al., 1995; O'Shea, 1997).
specific genes and activate gene transcription. Although We therefore decided to generate Jak1-deficient mice
the Jaks are known to play a critical role in this process, using homologous recombination techniques and deter-
the physiologic functions and fine specificities of these mine whether Jak1 deficiency leads to distinct biologic
enzymes remain poorly defined (Ihle et al., 1995; O'Shea, response deficits. In this report, we demonstrate that
1997). Jak1 indeed plays an essential and nonredundant role in
promoting biologic responses induced only by specific
subsets of cytokine receptors, including those in which§To whom correspondence should be addressed.
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generate animals heterozygote for the targeted deletion.
Heterozygote 3 heterozygote breedings produced wild-
type, heterozygote, and homozygote embryos as identi-
fied by Southern blot analyses (Figure 1B). Immunopre-
cipitation and Western blot analyses using Jak1 antisera
showed the presence of the 130 kDa Jak1 protein in
lysates of embryonic fibroblasts (EFs) derived from wild-
type embryos but not embryos homozygous for the dis-
rupted Jak1 gene (Figure 1C). EFs derived from hetero-
zygote embryos contained reduced amounts of Jak1
relative to wild-type EFs.
Cells from Jak1-Deficient Mice Fail To Develop
Biologic Responses to Ligands of
Class II Cytokine Receptors
Previously published work using a randomly mutagen-
ized human fibrosarcoma cell line indicated that Jak1
was required for both signaling and biologic response
induction by IFNa and IFNg (MuÈ ller et al., 1993). To
extend these observations to primary cells with a tar-
geted deletion of Jak1, we monitored the ability of the
interferons to enhance MHC class I expression on EFs
derived from wild-type and Jak1 null mice. Whereas
wild-type EFs exposed to either IFNa or IFNg expressed
enhanced levels of H2-Kb, Jak12/2 EFs were unrespon-
sive to either cytokine (Figure 2A). Similar results were
obtained when antiviral activity was monitored as a sec-
ond IFN-dependent biologic response (data not shown).
Figure 1. Targeted Disruption of the Jak1 Gene Ablates Expression To document that the unresponsive state was spe-
of Jak1 Protein cifically due to the absence of Jak1, immortalized EFs
(A) The genomic locus of the wild-type Jak1 gene, the targeting from Jak11/1 and Jak12/2 embryos were analyzed for
vector, and the disrupted Jak1 gene. The first three exons (I, II, IFN responsiveness before and after reconstitution with
and III) encoding the 59 region of the Jak1 protein, the neomycin Jak1. Immortalized Jak11/1 EFs responded to either
resistance cassette (Neo), and the thymidine kinase cassette (TK)
IFNa or IFNg in a dose-dependent manner and resistedare marked by shaded boxes. The orientation of transcription of
the cytopathic effects of vesicular stomatitis virus (Fig-Neo and TK are indicated by arrows. The restriction fragment used
ure 2B). In contrast, neither IFNa nor IFNg protectedas a probe external (Ext. Probe) to the targeting vector in Southern
analyses is marked. The locations of restriction sites for Eco RI (E), Jak12/2 fibroblasts from viral infection. However, IFN
Pst I (P), and Xba I (X) are indicated. responsiveness was restored to immortalized gene-tar-
(B) Southern blot analysis of Eco RI digested DNA isolated from the geted cells following stable transfection with a murine
tails of e16.5 embryos derived from the mating of heterozygote mice.
Jak1 expression plasmid. Reconstituted Jak12/2 EFsThe bands at 6.7 and 3.6 kb correspond to the endogenous and
also recovered the ability to up-regulate MHC class Imutant Jak1 genes, respectively.
expression in response to IFNa or IFNg (Figure 2A). Thus,(C) Two million EFs of each genotype were lysed and analyzed by
immunoprecipitation and Western blotting for the presence of Jak1. the IFN unresponsiveness observed in fibroblasts of our
gene-targeted mice is specifically due to the absence
of Jak1.
Jak utilization was originally thought to be nonspecific. We also tested whether Jak1 was required for devel-
These results thus demonstrate that the Jaks are utilized opment of IFN-dependent biologic responses in other
by cytokine receptors in a functionally dedicated man- cell types. Whereas macrophages from Jak11/1 em-
ner to promote development of cytokine-specific bio- bryos responded to the combination of LPS and either
logic responses. IFNa or IFNg and produced nitric oxide, macrophages
from Jak12/2 embryos did not (Figure 2C). Jak12/2 mac-
rophages also failed to up-regulate ICAM-1 expressionResults
(Figure 2E) or induce expression of the third component
of complement (data not shown) in response to IFNg.Generation of Jak1-Deficient Mice
To ablate the mouse Jak1 gene, a targeting construct However, Jak12/2 macrophages were not generally cy-
tokine unresponsive because they up-regulated ICAM-1was designed to replace the first two exons of the gene
and 1.6 kb of 59 upstream sequence with a neomycin following treatment with TNFa in a manner similar to
that of wild-type macrophages. Thus, the absence ofresistance cassette (Figure 1A). Following electropora-
tion and selection, 3 out of 235 ES cell clones were Jak1 results in a generalized cellular unresponsiveness
to type I and type II interferons.identified by Southernblot analysis as having undergone
successful gene targeting. Chimeric animals from two Based on the obligate requirement of Jak1 for biologic
responses induced through the receptors for IFNa andof these clones transmitted the mutation germline to
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Figure 2. Jak12/2 Cells Are Unresponsive to
Ligands that Utilize Class II Cytokine Re-
ceptors
(A) Primary Jak11/1 or Jak12/2 EFs, or immor-
talized Jak12/2 EFs stably transfected with
a Jak1 expression plasmid (Jak1 expressing
Jak12/2) were stimulated with IFNa (100 U/ml)
or IFNg (1000 U/ml) for 72 hr and analyzed for
expression of MHC class I by flow cytometry.
(B) Immortalized EFs were stimulated with
IFNa or IFNg and cultured with vesicular sto-
matitis virus. After 48 hr, surviving cells were
quantitated by vital dye staining.
(C) Fifty thousand in vitro differentiated mac-
rophages from Jak11/2 or Jak12/2 mice were
stimulated with LPS (5 ng/ml) plus different
doses of IFNg or IFNa for 48 hr and levels of
nitrite determined by ELISA.
(D) Five thousand macrophages from Jak11/1
or Jak12/2 mice were incubated with IL-10 for
60 min followed by treatment with LPS (10
ng/ml). After 24 hr TNF in culture superna-
tants were quantitated by ELISA.
(E) Macrophages from either Jak11/2 or
Jak12/2 mice were stimulated for 48 hr with
IFNg (1000 U/ml) or TNFa (100 ng/ml) and
levels of ICAM-1 determined by flow cy-
tometry.
IFNg, we examined whether this enzyme is also required initiated. By examining litters at different stages of em-
for biologic responses induced by the IL-10 receptor, bryonic development from e3.5±e19.5, we could identify
the third known member of the class II cytokine receptor viable Jak12/2 embryos in numbers that approximated
superfamily (Ho et al., 1995). Whereas macrophages de- Mendelian proportions throughout gestation. Moreover,
rived from wild-type embryos responded to IL-10 in a viable Jak12/2 neonates were found in litters immedi-
dose-dependent manner by inhibiting LPS-induced ately after delivery. However, within 24 hr of birth, all
TNFa production, macrophages from Jak12/2 mice did Jak12/2 pups were dead, and no Jak12/2 mouse has
not (Figure 2D). Thus, Jak1 plays an obligate role in survived more than 24 hr among the 326 mice produced
mediating biologic responses, which are manifest by by the breeding effort. Identical results were found when
each of the class II cytokine receptor family members. breeding was conducted using a second Jak1 gene±
targeted ES cell clone or when Jak1 heterozygote mice
were generated on different geneticbackgrounds. Thus,Deficiency in Jak1 Results in Perinatal Lethality
homozygous Jak1 deficiency results in a perinatal le-Having confirmed the successful generation of Jak12/2
thality.offspring through analysis of embryonic tissues, a large
scale heterozygote 3 heterozygote breeding effort was Gross external examination of Jak12/2 mice failed to
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Figure 3. Jak12/2 Mice Exhibit Deficits in
Lymphopoiesis but Not Myelopoiesis
(A, C, and E) Cellular recoveries from thymi
(A) spleens (C) and weight of livers (E) derived
from newborn Jak11/1 (open boxes) and
Jak12/2 (filled boxes) mice.
(B) Thymocytes derived from newborn
Jak11/1 (left panel) and Jak12/2 (right panel)
mice were stained with FITC anti-CD4 and PE
anti-CD8 and analyzed by flow cytometry.
(D) Splenocytes derived from newborn
Jak11/1 (left panel) and Jak12/2 (right panel)
mice were stained with FITC anti-IgM and PE
anti-B220 and the gated lymphoid population
analyzed by flow cytometry.
(F) Fetal liver cells derived from e18.5 Jak11/1
(left panel) and Jak12/2 (right panel) animals
were stained with FITC anti-Mac-1 and PE
anti-Gr-1 and the gated myeloid populations
analyzed by flow cytometry.
The percentage of the total gated cells ana-
lyzed is given within each quadrant.
reveal significant developmental abnormalities com- reduction in cellularity. Nevertheless, the distribution of
CD4- and CD8-positive cells within the wild-type andpared to Jak1-sufficient newborns. However, newborn
Jak12/2 mice (0.99 6 0.11 g) weighed 40% less than Jak12/2 thymocyte populations was similar (Figure 3B).
The thymi of gene-targeted mice contained a slightlytheir heterozygote (1.61 6 0.16 g) or wild-type (1.65 6
0.09 g) littermates. Moreover, Jak1-deficient neonates higher percentage of CD42CD82 cells relative to con-
trols. However, these cells most likely represent stromalfailed to nurse despite a normal nurturing behavior of
the mothers even when these mice were part of very cells, which contaminate the limited number of thymo-
cytes that can be isolated from newborn Jak12/2 mice.small litters or when all Jak1 sufficient siblings were
removed from the litter (data not shown). Thus, Jak1 deficiency results in a primary defect in thy-
mocyte production rather than a definitive block in thy-
mocyte maturation.Severely Impaired Lymphocytic Development
in Jak1-Deficient Mice To determine whether B cell production and/or devel-
opment was also dependent on Jak1, the B cell lineagesBlood from newborn Jak12/2 mice contained normal
numbers of erythrocytes, mononuclear phagocytes, neu- present in the spleens and livers of wild-type and gene-
targeted mice were quantitated. No significant differ-trophils, and platelets (data not shown). Moreover, upon
necropsy of newborn Jak1 null pups, no gross abnor- ences in total splenocyte numbers were observed be-
tween newborn wild-type and Jak12/2 mice (Figure 3C).malities were found in several organs, such as heart,
liver, lungs, kidney, and brain. In contrast, thymi from This result is consistent with the fact that spleens of
newborn mice contain only a limited number of lymphoidnewborn Jak12/2 mice were of severely reduced size
compared to those isolated from control newborn lit- cells. However, when the B cells present in the spleens
of Jak1-sufficient and Jak1-deficient mice were quanti-termates. Histologic examination of comparable cross
sections of Jak1-sufficient and Jak1-deficient litter- tated by monitoring expression of the B220 and IgM cell
surface markers, Jak1 null mice were found to displaymates revealed the presence of abundant developing
thymocytes in wild-type mice but a severely reduced profound abnormalities in the B cell compartment.
Compared to spleens of wild-type littermate controls,number of thymocytes in Jak1 null mice. Both types of
animals displayed normal thymic epithelial architecture. Jak12/2 spleens contained 40-fold fewer double positive
B cellsand 7- to10-fold fewer B2201, IgM2 B cell precur-To examine the thymocyte deficiency in detail, the
cellularities of thymi from wild-type and Jak1 null mice sors (Figure 3D). Identical results were obtained using B
cells from fetal livers (data not shown). Since the B2201,were compared (Figure 3A). An average thymus from a
newborn wild-type mouse contained 182 6 85 3 105 IgM2 cell population in normal mice contains pro± and
pre±B cells, NK cells, and a subpopulation of T cells,(mean 6 SD, n 5 12) thymocytes. In contrast, an average
thymus from a Jak12/2 mouse containedonly 0.7 6 0.6 3 we analyzed it for expression of CD43, a marker that is
expressed on pro±B cells but not on pre±B cells (Hardy105 thymocytes (n 5 17), which represents a 260-fold
Cytokine Response Deficits in Jak12/2 Mice
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et al., 1991). Whereas 49.7% of the wild-type cells in
this population expressed the CD43 marker, more than
90% of the B2201, IgM2 splenocytes derived from Jak1
null mice were CD43 positive (data not shown). Thus,
Jak1 deficiency leads to a developmental blockade of
B lymphocyte differentiation at the pro±B to pre±B cell
transition step and results in a profound deficit in the
generation of mature B lymphocytes.
In contrast to the lymphoid compartment deficiencies,
no significant abnormalities were observed in total liver
weight or in Mac-11 and/or Gr-11 myeloid cells derived
from fetal liver or newborn spleen of Jak1 null mice
(Figures 3E and 3F). Thus, the hematopoietic defects of
Jak12/2 mice are limited exclusively to the lymphoid
compartment. To date, we have been unable to repopu-
late the lymphoid compartment of irradiated Jak11/1
mice with Jak12/2 fetal liver cells despite successful
reconstitution with wild-type fetal liver cells (data not
shown).
Abnormal Lymphoid Cell Development Is Due
to IL-7 Receptor Dysfunction Caused
by the Absence of Jak1
A number of cytokines that promote hematopoiesis, in-
Figure 4. Jak12/2 Hematopoietic Cells Exhibit Selective Unrespon-cluding IL-3, IL-5, GM-CSF, G-CSF, and IL-7, have been
siveness to Lymphopoietic Cytokines that Use Receptors that Con-reported toactivate Jak1 using different in vitro signaling
tain the gc Receptor Subunitassay systems (Ihle et al., 1995). To obtain insights into
(A) Fetal liver cells from e15.5±e17.5 Jak1-sufficient or Jak1-deficientthe molecular basis of the lymphopoietic defects in the
embryos were plated in duplicate methylcellulose cultures supple-
Jak1 null mice, we utilized methylcellulose colony form- mented with either no factor, IL-7 (10 ng/ml), GM-CSF (12 ng/ml),
ing assays to determine whether any of the receptors IL-3 (16 ng/ml), IL-5 (100 ng/ml), G-CSF (13.3 U/ml), or M-CSF (33.3
for the known hematopoietic cytokines display an oblig- U/ml). After 7±8 days of culture, total colonies (.50 cells) visible at
103 magnification were enumerated.atory requirement for Jak1 for growth and/or survival of
(B) Duplicate cultures of 1 3 105 thymocytes from newborn Jak11/1hematopoietic precursor cells (Figure 4A). Fetal liver
(open bars), Jak11/2 (light shaded bars), or Jak12/2 (dark shadedcells from Jak1-sufficient and Jak1-deficient embryos
bars) mice were stimulated with medium, PMA, or PMA in combina-
formed equivalent numbers of colonies in response to tion with muIL-7 (100 ng/ml), muIL-2 (25 ng/ml), muIL-4 (25 ng/
M-CSF, G-CSF, GM-CSF, and IL-5. IL-3 also induced ml), or ionomycin, and proliferative responses were determined by
colony formation in Jak1 null fetal liver cells; however, quantitating 3H-thymidine uptake.
these colonies were somewhat reduced in number and
significantly reduced in size (Figure 4A and data not
shown). In contrast, whereas wild-type and heterozy- from Jak1 null mice expressed the gc subunit and the
IL-4 receptor a subunit at levels comparable to wild-gote fetal liver cells formed colonies when incubated
with IL-7 at 10 ng/ml, no colonies were observed in type cells (data not shown). Thus, Jak1 deficiency leads
to the ablation of lymphopoiesis in response to many ifcultures of IL-7±treated Jak12/2 cells. Similar experi-
ments performed with higher doses of IL-7 (50 ng/ml) not all cytokine receptors that utilize the gc, including
the IL-7 receptor. Since IL-7 is known to act early andor using cells isolated from newborn spleen instead of
fetal liver yielded identical results (data not shown). specifically during lymphocyte development to promote
lymphocyte survival (Akashi et al., 1997), the lymphopoi-The lack of IL-7±induced Jak12/2 cell colony formation
was confirmed using cell proliferation assays in liquid etic deficiencies in the Jak12/2 mouse can be linked to
the absence of IL-7 receptor function.culture (Figure 4B). Whereas Jak1-sufficient thymocytes
proliferated when cultured with IL-7 plus phorbol ester,
Jak1 null thymocytes did not. Since the IL-7 receptor Signaling via the IL-6 and LIF Receptors Is Deficient
but Not Abolished in Jak1 Null Cellsbelongs to the family of cytokine receptors that also
includes the receptors for IL-2, IL-4, IL-9, and IL-15 that The aforementioned data showed that Jak1 is used in
a highly specific and restricted manner by particularshare a common subunit (the gc chain), the proliferation
of Jak1-sufficient and Jak1-deficient thymocytes in re- cytokine receptors. We therefore asked whether Jak1
played a similar dedicated role in mediating signalingsponse to IL-2 and IL-4 was also examined. As was the
case for IL-7, IL-2 and IL-4 induced proliferation of Jak1- and biologic response induction by the gp130 family of
cytokine receptors that has been reported to use thesufficient thymocytes but not Jak1 null thymocytes. In-
terestingly, Jak12/2 thymocytes were also unresponsive Jaks in a nonspecific manner (Stahl et al., 1994).
To test whether Jak1 is required for gp130 receptorto the combination of PMA and ionomycin, a result that
suggests that Jak12/2 thymocytes may have an inherent family signaling, macrophages, EFs, and cardiomyo-
cytes from Jak1-sufficient and Jak1-deficient mice weresurvival defect. FACS analysis revealed that thymocytes
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clearly point to a major quantitative contribution of Jak1
to the signaling response. As expected, STATs were
activated in wild-type but not Jak12/2 macrophages,
and EFs were exposed to IFNg. Moreover, Jak12/2 mac-
rophages retained the ability to activate STATs in re-
sponse to IL-3 and GM-CSF (Figure 5A), and Jak12/2
fetal liver cells activated STATs when treated with GM-
CSF, IL-3, or EPO (data not shown).
Lack of Biologic Response Induction to gp130
Receptor Family Ligands in Jak12/2 Mice
Since Jak1 null cells displayed only a limited capacity
to activate the Jak-STAT signaling pathway when chal-
lenged with ligands for the gp130 receptor family, we
asked whether partial signaling was of sufficient magni-
tude to induce biologic responses in the treated cells.
Cardiomyocytes from control newborn mice manifest a
hypertrophic response when incubated with either IL-6,
LIF, or CT-1 (Figure 6), similar to that previously reported
for normal rat cardiomyocytes (King et al., 1996). In con-
trast, no hypertrophy was induced in cells from Jak12/2
mice. Thus, the quantitative signaling deficiency ob-
served in the Jak12/2 cardiomyocytes translates into a
qualitative biologic response deficit.
Ligands of the gp130 receptor family play important
roles in neuronal development and survival (Dechiara et
al., 1995; Li et al., 1995; Ware et al., 1995). We therefore
examined whether Jak12/2 neurons were capable of re-
sponding to neurotrophic cytokines. Neurons from dor-
sal root ganglions (DRGs) of control newborn mice cul-
tured in the absence of growth factor died after 72 hr
in culture, as evidenced by the absence of immunostain-
ing for Neurofilament M (Figure 7A). However, neuronal
viability was maintained if the cells were cultured in the
presence of either nerve growth factor (NGF) or LIF.
Viability of neurons from newborn Jak12/2 mice was also
preserved by NGF. However, almost no viable Jak12/2
neurons were detected following 3 day culture in the
presence of LIF.
Usingthis assay system, the response of DRG sensory
Figure 5. Diminished but Detectable STAT Activation following
neurons to a wider range of gp130 receptor family li-Stimulation of Jak12/2 Cells with Ligands that Utilize gp130 and/or
gands was quantitated. Whereas LIF, CNTF, OSM, CT-1,LIFRb
and the combination of IL-6 1 IL-6Ra individually pre-Five million macrophages (A) derived from Jak11/2 or Jak12/2 mice,
served theviability of Jak1-sufficient neurons to approx-one million EFs (B) derived from Jak11/2 or Jak12/2 mice, or one
million cardiomyocytes (C) derived from Jak11/2 or Jak12/2 mice imately 75% of that induced by NGF (Figure 7B, top
were stimulated with either buffer alone, human IL-6 (400 ng/ml) panel), none of these cytokines was able to maintain
and human IL-6Ra (500 ng/ml), murine LIF (400 ng/ml), murine IL-3 viability of Jak1-deficient neurons in culture (Figure 7B,
(200 ng/ml), or murine GM-CSF (200 ng/ml) for 15 min or murine
bottom panel). In contrast, NGF was capable of pre-IFNg (1000 u/ml) for 10 min. Cells were lysed and DNA binding
venting apoptosis of Jak12/2 neurons. In situ hybridiza-activity quantitated by EMSA.
tion revealed the presence of LIF receptor b chain mRNA
in DRG neurons of either wild-type or Jak12/2 mice (data
stimulated in vitro with different cytokines and Stat acti- not shown). These results thus demonstrate a central
vation assessed using an electrophoretic mobility shift role for Jak1 in neuronal development and/or survival
assay (Figure 5). All cell types derived from Jak1-suffi- and strongly suggest that gp130 receptor family mem-
cient animals activated Stat3 (and in some cases Stat1) bers display an obligate requirement for Jak1 to induce
in response toeither IL-6 or LIF. In contrast, Stat3 activa- at least a subset of their cellular responses.
tion was diminished but detectable in Jak12/2 cells stim- Interestingly, the total number of Jak1 null neurons
ulated with IL-6 (50%, 85%, and .95% reduction for surviving 3 day culture with NGF was 33%±50% lower
macrophages, EFs, and cardiomyocytes, respectively) than that of Jak1-sufficient neurons. This result sug-
and was almost completely abolished (.95%) but still gested that Jak12/2 mice might have an inherent neu-
detectable in Jak12/2 cells treated with LIF. Whereas ronal deficit. To examine this possibility, we quantitated
these results are consistent with the observations of recovery of DRG sensory neurons from wild-type, het-
erozygote, or Jak1 null mice examined 2, 24, or 72 hrothers (Stahl et al., 1994; Guschin et al., 1995), they
Cytokine Response Deficits in Jak12/2 Mice
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Figure 6. Jak12/2 Cardiomyocytes Fail To
Undergo a Hypertrophic Response to LIF,
CT-1, or IL-6
(A) One representative dose response experi-
ment of Jak11/2 (open symbols) or Jak12/2
(closed symbols) cardiomyocytes plated in
duplicate cultures and stimulated with the in-
dicated amounts of cytokine for 48 hr. Cul-
tures were fixed, stained, and the surface
areas of 30 cells/dose quantitated and av-
eraged.
(B) Mean values of three independent experi-
ments of Jak11/2 (open boxes) and Jak12/2
(shaded boxes) cardiomyocyte surface areas
following treatment with LIF (1 nM), CT-1 (1
nM), or IL-6 1 IL-6Ra (500 ng/ml).
after isolation and culture in NGF. At each time point, the IFNs requires Jak-STAT pathway signaling (Durbin
et al., 1996; Meraz et al., 1996). However, the demon-significantly lower numbers of neurons were found in the
stration that Jak1 is needed for induction of IL-10±depen-Jak12/2 cultures compared to cultures established with
dent responses has not been previously demonstrated.Jak1-sufficient cells (Figure 7C and data not shown).
This result thus establishes that Jak1 is the commonThese results indicate that Jak1 may be necessary in
Jak-STAT signaling pathway component, which is sharedvivo to promote survival of at least certain subsets of
by all members of the class II cytokine receptor family.neurons.
Jak1 deficiency in mice led to severely reduced num-
bers of thymocytes, pre±B cells, and mature T and BDiscussion
lymphocytes but did not lead to alterations in the devel-
opment of other hematopoietic lineages. This result thusAlthough Jak1 is a globally expressed Janus kinase,
demonstrates that in hematopoiesis, Jak1 is required
which is activated by a wide variety of cytokines, its
only by cytokine receptors that selectively induce devel-
requirement in the induction of cytokine-specific bio-
opment of lymphoid cell populations. Through the use
logic responses remains largely undefined (Ihle et al.,
of colony forming assays and proliferation assays, Jak1
1995; O'Shea, 1997). The purpose of this study was to
was shown to be required for IL-7±dependent lympho-
identify those cytokine receptors that demonstrate an
poietic responses. Cells from Jak12/2 mice thus show
obligate dependency on Jak1 for induction of cellular
a hematopoietic deficit similar to that observed in mice
responses. Our results show that Jak1 plays an indis- that lack IL-7, the IL-7 receptor a chain, orJak3 (Peschon
pensable role in mediating biologic responses induced et al., 1994; Nosaka et al., 1995; Park et al., 1995; Thomis
by three major cytokine receptor subfamilies: class II et al., 1995; von Freeden-Jeffry et al., 1995). These mice
cytokine receptors (i.e., the receptors for IFNa/b, IFNg, exhibit substantial reductions in T and B cell numbers
and IL-10), cytokine receptors that utilize the gc receptor but do not display an absolute block in lymphocyte de-
subunit (i.e., the receptors for IL-2, IL-4, IL-7, IL-9, and velopment. Recently, the deficits expressed in IL-7 unre-
IL-15), and receptors that utilize the gp130 subunit (i.e., sponsive mice have been shown to be a result of the
receptors for IL-6, IL-11, LIF, OSM, CNTF, and CT-1). absence of a survival signal provided to developing cells
These results demonstrate that under physiologic con- through the IL-7 receptor (Akashi et al., 1997). Our re-
ditions, the Jaks play dedicated and nonredundant roles sults reveal that IL-7 receptor±induced responses re-
in effecting cytokine specific biologic responses. quire Jak1 as well as Jak3 and demonstrate that Jak1
The results from analyses of cells and tissues derived is the obligate partner for Jak3 for inducing the survival
from Jak12/2 mice demonstrate that there is an absolute signal. In addition, thymocytes from Jak1 null mice failed
requirement for Jak1 in mediating biologic responses to respond to other lymphopoietic cytokines such as
to IFNa and IFNg. This result is thus in agreement with IL-2 and IL-4 that associate with distinct ligand binding
earlier studies showing that mutant human tumor cell receptor subunits but also incorporate gc as part of their
lines which lack Jak1 are IFN-unresponsive (MuÈ ller et activated receptor complexes (Leonard et al., 1995).
These results demonstrate the generality of the pairingal., 1993) and that induction of all biologic responses to
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Figure 7. Ligands that Utilize the gp130 Re-
ceptor Family Fail To Prevent Apoptosis of
Jak12/2 Sensory Neurons
(A) DRG neurons from newborn Jak11/2 or
Jak12/2 mice were cultured in the presence
of anti-NGF alone (None), NGF alone (50 ng/
ml) (NGF), or anti-NGF plus LIF (10 ng/ml)
(LIF) for 72 hr. Cultures were fixed, stained
for Neurofilament M, and photographed at
203 magnification.
(B) DRG neurons isolated from newborn
Jak11/2 (top panel) or Jak12/2 (bottom panel)
mice were cultured for 72 hr with anti-NGF
(none), NGF (50 ng/ml), or anti-NGF and LIF
(50 ng/ml), CNTF (100 ng/ml), OSM (100 ng/
ml), CT-1 (125 ng/ml), or IL-6 1 IL-6Ra (125
ng/ml). Viable cells were stained with crystal
violet and/or Neurofilament M and quanti-
tated.
(C) Number of neurons recovered from spinal
cord DRGs of newborn Jak11/1, Jak11/2, and
Jak12/2 mice 2 hr after plating.
of Jak1 and Jak3 for biologic responses induced by activate both Jak1 and Jak2 in in vitro assays (Nicholson
et al., 1994; Ihle et al., 1995; Kouro et al., 1996).all lymphopoietic receptors that utilize the gc receptor
subunit. Moreover, they show that Jak1 is not required The most surprising aspect of this study is the finding
that ligands for receptors that signal through the gp130by other hematopoietic receptors, such as those that
bind GM-CSF or G-CSF, which have been reported to receptor subunit fail to induce at least certain biologic
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responses in Jak1-deficient cells. These results thus (Li et al., 1995; Ware et al., 1995). Both types of gene-
targeted mice are significantly smaller than their lit-directly address the controversy concerning the dedi-
cated usage of Jaks by this family of cytokine receptors. termates at birth, fail to nurse, and die perinatally. In
addition, neurons from both types of mice are unableExtensive work using cultured tumor cell lines and over-
expression approaches led to the concept that Jaks to respond to the ligands of the gp130 receptor family
and die by apoptosis. In the absence of the LIFRb sub-may be used in a nonspecific manner by the receptors
for IL-6, IL-11, LIF, OSM, CNTF, and CT-1 to initiate unit, newborn mice display decreased numbers of motor
neurons. Although we have not yet quantitated motorsignaling (Stahl et al., 1994). Although this receptor fam-
ily is known to control a wide variety of important devel- neurons in the Jak12/2 mice, it is striking that the num-
bers of sensory neurons isolated from these mice wereopmental, immune, and inflammatory responses (Kishi-
moto et al., 1995), no biologic responses were examined reduced compared to those isolated from Jak1-suffi-
cient mice. Thus, it is possible that a neuronal defect inin the earlier studies. This concept was subsequently
challenged by an independent study showing that Jak1 the Jak1 null mice secondary to a lack of signaling
through receptors that employ the LIFRb subunit is thewas necessary for IL-6±dependent induction of an im-
mediate early gene (IRF-1) in a human fibrosarcoma cell cause of the perinatal lethality. Work is currently under-
way to examine this possibility.line (Guschin et al., 1995). Our results show that ligands
that bind to gp130 receptor family members, although
Experimental Procedurescapable of inducing weak activation of the Jak-STAT
pathway in different Jak1-deficient cell types, fail to pro-
Cytokines, Reagents, and General Proceduresvoke a biologic response in primary nontransformed
Purified recombinant cytokines were obtained from the followingcardiomyocytes or neurons. Importantly, in the case of
sources: MuIFNg and MuCT-1 from Genentech (South San Fran-
cardiomyocytes, the discordance between initiation of cisco, CA); HuIFNaA/D from Dr. Michael Brunda, Hoffmann-LaRoche
signaling and the induction of biologic responses was (Nutley, NJ); HuIL-6 and IL-6Ra chain was kindly provided by Dr.
Tetsuya Taga of Osaka University (Osaka, Japan); GM-CSF wasnoted in the same cell type. Thus, although other Jaks
provided by Dr. Satwant Narula, Schering-Plough Research Institutemay indeed be able to compensate to some degree for
(Kenilworth, NJ); HuM-CSF, MuIL-3, and human and murine IL-7the absence of Jak1 to initiate the signaling process,
from Genzyme Corporation (Cambridge, MA); MuIL-5, HuEPO, and
this compensation is not sufficient to result in the devel- MuOSM from R&D Systems (Minneapolis, MN); LIF from GIBCO/
opment of a full cellular response. These observations BRL (Gaithersburg, MD); NGF from Harlan Bioproducts (Madison,
establish that development of biologic responses in- WI); and rat CNTF was provided by Dr. Richard Scott and Dr. Sheryl
Meyer, Cephalon (West Chester,PA). A cDNA-encoding murine Jak1duced via the Jak-STAT pathway occur only when the
was provided by Dr. S. Nagata of Osaka Bioscience Institute (Osaka,level of signaling exceeds some, as yet undefined,
Japan). All experiments presented were performed at least threethreshold value.
times.Interestingly, the phenotype of Jak12/2 mice is distinct
from that displayed by mice with targeted disruption of Targeting Vector
gp130 (Yoshida et al., 1996) or Jak2 (Neubauer et al., Genomic clones containing portions of the murine Jak1 gene were
1998; Parganas et al., 1998 [both in this issue of Cell]). isolated from a Lambda Fx II murine 129/Sv genomic library (Stra-
tagene, LaJolla, CA). To generate the Jak1 targeting vector, a 5.5 kbDeficiency in gp130 results in malformation of the ven-
Xba-Xba fragment containing exon 3 was inserted into the targetingtricular walls of the heart and leads to embryonic lethality
vector pTK.NEO.UMS as previously described (Meraz et al., 1996)between e14.5±e17.5 p.c. Jak12/2 mice exhibited no de-
such that its 39 end was adjacent to the polyoma enhancer promoter
velopmental heart abnormalities and survived to the first driven herpes simplex virus thymidine kinase gene. The 59 end of the
postnatal day of life. Moreover, no heart abnormality targeting construct was generated from a 1.6 kb PstI-PstI fragment
was found in Jak12/2 pups at the time of their perinatal upstream of exon I (Figure 1).
death. These results show that Jak1 is not required for
Transfection of ES Cells and Generationat least certain gp130-dependent events that lead to
of Jak1-Deficient Micecardiac development and thereby lend support to the
The GS-1 embryonic stem cell line was cultured as described(Huangconcept that gp130 can activate multiple signal trans-
et al., 1993). ES cells were electroporated with 20 mg of Sac II
duction pathways that give rise to distinct biologic re- linearized targeting construct per 1 3 107 cells and grown under
sponses (Kishimoto et al., 1995). Jak2 deficiency results double selection as described (Meraz et al., 1996). Two hundred and
in an embryonic lethality due to a lack of definitive eryth- thirty five colonies were analyzed for homologous recombination by
PCR using a sequence derived from the external probe (Figure 1).ropoiesis. Importantly, cells from Jak22/2 mice display
Three positive clones (C4, L3, and 1A15) were identified by PCR,cytokine response deficits that are nearly complemen-
confirmed by Southern blotting, and microinjected into blastocysts.tary to those observed in our Jak12/2 mice. Like Jak12/2
Two clones (C4 and 1A15) transmitted the mutation germline and
cells, Jak22/2 cells do not respond to IFNg. However, thus produced two independent lines of Jak12/2 mice.
unlike Jak12/2 cells, Jak22/2 cells manifest biologic
responses to IL-6 and IFNa/b and can repopulate the Genotyping by Southern Blot and PCR
lymphoid compartment of irradiated lymphocyte-defi- Southern blot analysis was performed on 25 mg of Eco RI digested
genomic DNA as described (Meraz et al., 1996). Filters were probedcient mice but fail to respond to erythropoietin, IL-3,
with a 32P-labeled external probe (Figure 1). To genotype mice byor thrombopoietin. Thus, the combined data obtained
PCR, 0.5 mg of genomic DNA was amplified with one set of primersthrough the analysis of Jak1- and Jak2-deficient mice
derived from the neomycin gene (59 sequence: CACGACGGGCGTT
unequivocally demonstrate the specific utilization of the CCTTGCGCAG, 39 sequence: CCTGATGCTCTTCGTCCAGATCAT)
Jaks by cytokine receptors. and a second set of primers derived from the second exon of the
In contrast, the phenotypes of the Jak12/2 mice and Jak1 gene deleted by the targeting construct (59 sequence: GAGGAC
TGCAATGCCATGGCGTTC, 39 sequence: CACTCCTGGGCGGCCCmice lacking the LIFRb subunit are remarkably similar
Cell
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TGATG). The samples were amplified in the following manner: 1 60 min. Medium (MEM supplemented with 10% FCS, 2 mM L-gluta-
mine, 100 mg/ml penicillin and streptomycin, 20 mM fluorodeoxyuri-cycle at 948C for 1 s; 25 cycles at the following conditions: 948C for
30 s, 628C for 45 s, and 728C for 45 s; and finally 1 cycle at 728C for dine, and 20 mM uridine) was then added and the neurons triturated
using a Pasteur pipette. Dissociated ganglia were plated into colla-2 min. A 200 bp fragment derived from exon 2 and a 250 bp fragment
derived from the neomycin gene wereresolved on a 2% TBE agarose gen-coated 24-well tissue culture dishes or collagen-coated glass
chamber slides in MEM media supplemented with cytokine and/orgel.
goat anti-murine NGF at a final dilution of 1/500. After 72 hr, cells
were fixed in 4% formalin, stained with crystal violet or anti-Neuro-Jak1 Western Blots
filament M (Chemicon International, Temecula, CA), and the numberImmunoprecipitation and Western blotting were performed on ly-
of viable cells enumerated by microscopy (Gribaudo et al., 1985).sates of EFs as described (Meraz et al., 1996) using different Jak1-
specific antisera obtained from Upstate Biotechnology Institute
(Lake Placid, NY) and Santa Cruz Biotechnology (Santa Cruz, CA). Acknowledgments
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